22087026

Hogg K

2012

Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome.

22088131

Sivayoganathan D

2011

Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity.

22088206

Crisosto N

2012

Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.

22088801

Beydoun HA

2012

Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States.

22090274

Lungu AO

2012

Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome.

22090801

Kawamura S

2011

Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population.

22091248

Khani B

2011

Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome.

22091305

Mehrabian F

2011

The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.

22092488

Weiss TR

2011

Young women's experiences living with polycystic ovary syndrome.

22093937

Xiang L

2011

[Effects of magnesium valproate on endocrine system and reproductive functions of female epileptics].

22096008

Melo AS

2011

The frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenism.

22096112

Sathyapalan T

2012

Recent advances in cardiovascular aspects of polycystic ovary syndrome.

22100168

Ery?lmaz ?G

2012

Ultrasonographic measurement of?the femoral cartilage thickness in?patients with polycystic ovary syndrome.

22102291

de Sousa G

2012

Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome.

22102927

Roe AH

2011

The diagnosis of polycystic ovary syndrome in adolescents.

22103710

Ozkaya E

2012

Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?

22103769

Lee HJ

2012

A comparative study on the impact of fresh variables on the success of frozen-thawed embryo transfer cycles using 2PN sibling embryos in women with/without polycystic ovary syndrome.

22103791

Yilmaz N

2012

The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.

22104628

Insenser M

2011

Application of proteomics to the study of polycystic ovary syndrome.

22106998

Inder WJ

2011

No evidence of benefit for universal screening with 75 g oral glucose tolerance test in polycystic ovary syndrome.

22107332

Golbahar J

2012

Leptin-to-adiponectin, adiponectin-to-leptin ratios, and insulin are specific and sensitive markers associated with polycystic ovary syndrome: a case-control study from Bahrain.

22107839

Skrgatic L

2012

CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.

22108285

Araki T

2011

Achieving a successful pregnancy in women with polycystic ovary syndrome.

22108382

Meyer ML

2012

Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.

22112520

Savastano S

2011

Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS.

22114112

McGee WK

2012

Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.

22115162

Unuane D

2011

Endocrine disorders & female infertility.

22115171

Phelan N

2011

Management of ovarian disease in pregnancy.

22115703

Mejia-Montilla J

2012

[Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].

22116069

Guediche N

2012

Array comparative genomic hybridization analysis of small supernumerary marker chromosomes in human infertility.

22117616

Viollet B

2012

Cellular and molecular mechanisms of metformin: an overview.

22120941

Gray S

2011

Tales from the menopause clinic: practice observed.

22122627

D'Anna R

2012

Myo-inositol may prevent gestational diabetes in PCOS women.

22122754

Wiser A

2012

Controlled ovarian hyperstimulation in women with polycystic ovarian syndrome with or without intrauterine insemination.

22125108

Olszewska M

2011

[Methods of hair loss evaluation in patients with endocrine disorders].

22127370

Dokras A

2012

Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis.

22128296

Homburg R

2012

Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study.

22131240

Aleyasin A

2011

Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.

22132526

Garad R

2011

An evidence-based guideline for polycystic ovary syndrome.

22132633

Sarapatkov? H

2011

[Basic anthropometric characteristics and their relationship with the metabolism of saccharides in women with PCOS].

22133908

Pundir J

2012

Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?

22136153

Zhou N

2012

Increased arterial stiffness in mildly-hypertensive women with polycystic ovary syndrome.

22136882

Galazis N

2012

Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome.

22136944

Noll-Hussong M

2011

[Schizophrenic psychosis with polycystic ovarian syndrome and lupus erythematosus].

22137570

Kanmaz-?zer M

2012

Polymorphisms of vascular cell adhesion molecule1 (VCAM1) in polycystic ovary syndrome determined by quantitative real-time polymerase chain reaction and melting curve analysis.

22143833

Fauser BC

2011

Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age.

22144220

Beda-Maluga K

2011

The detection of macroprolactin by precipitation and ultrafiltration methods.

22144419

Panidis D

2012

Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.

22145457

Sopher AB

2011

Retinol-binding protein 4 correlates with triglycerides but not insulin resistance in prepubertal children with and without premature adrenarche.

22147920

Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

2012

Consensus on women's health aspects of polycystic ovary syndrome (PCOS).

22152901

Dumont T

2011

Pediatric synchronous bilateral ovarian torsion: a case report and review of the literature.

22153789

Fauser BC

2012

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

22154367

Stener-Victorin E

2012

Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.

22154711

Petr?kov? J

2012

Ovarian failure and polycystic ovary syndrome.

22154764

Sara L

2012

Arteriolar insulin resistance in a rat model of polycystic ovary syndrome.

22154766

Vanky E

2012

Androgens and antim?llerian hormone in mothers with polycystic ovary syndrome and their newborns.

22158730

S?rensen LB

2012

Effects of increased dietary protein-to-carbohydrate ratios in women with polycystic ovary syndrome.

22161461

Smith ML

2011

Endocrinology and recurrent early pregnancy loss.

22165685

Galletta M

2011

Bye-bye chiro-inositol - myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction.

22165724

Mici? DD

2011

[Sleep and metabolic disorders].

22168506

Baskol G

2012

Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome.

22168920

Eilertsen TB

2012

Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study.

22169760

Jamal M

2012

Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis.

22170719

Chen H

2012

Impaired CFTR-dependent amplification of FSH-stimulated estrogen production in cystic fibrosis and PCOS.

22172592

Escobar-Morreale HF

2012

Surgical management of metabolic dysfunction in PCOS.

22172593

Burt Solorzano CM

2012

Neuroendocrine dysfunction in polycystic ovary syndrome.

22173246

Cho LW

2011

Metabolic syndrome.

22173824

H?zl? D

2012

The impact of birth weight and maternal history on acne, hirsutism, and menstrual disorder symptoms in Turkish adolescent girls.

22176470

Park E

2012

Stress-induced activation of ovarian heat shock protein 90 in a rat model of polycystic ovary syndrome.

22176823

Rodr?guez-Flores M

2011

[The polycystic ovary syndrome. The point of view of the internist].

22178088

Hill LD

2012

Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome.

22178257

Dokras A

2012

Mood and anxiety disorders in women with PCOS.

22178785

Jones MR

2012

Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS).

22178786

Carmina E

2012

Androgen disorders.

22178787

Gonz?lez F

2012

Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.

22178788

Ehrmann DA

2012

Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea.

22180642

Goodarzi MO

2012

Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts.

22182833

Duleba AJ

2012

Medical management of metabolic dysfunction in PCOS.

22183129

Dunaif A

2011

Polycystic ovary syndrome in 2011: Genes, aging and sleep apnea in polycystic ovary syndrome.

22189518

Moghetti P

2012

For what reasons should metformin be used in the management of polycystic ovary syndrome?

22192134

Franks S

2012

Does PCOS have developmental origins?

22192135

Duleba AJ

2012

Is PCOS an inflammatory process?

22192136

Hoeger KM

2012

Do women with PCOS have a unique predisposition to obesity?

22192137

Marshall JC

2012

Should all women with PCOS be treated for insulin resistance?

22192350

Panidis D

2012

Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.

22194988

Vinaixa M

2011

Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovary syndrome after pioglitazone-flutamide-metformin polytherapy.

22197603

Fan P

2012

Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.

22197663

Wild RA

2012

Dyslipidemia in PCOS.

22200176

Costa EC

2012

Defining exercise prescription in lifestyle modification programs for overweight/obese polycystic ovary syndrome women.

22201076

Chanukvadze D

2011

Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.

22203091

Gungor Ugurlucan F

2012

Ovarian hyperstimulation syndrome in a patient with frozen-thawed embryo transfer and dichorionic diamniotic pregnancy.

22205343

Rashidi B

2012

Prevalence of the insulin receptor substrate-1(IRS-1) Gly972Arg and the insulin receptor substrate-2(IRS-2) Gly1057Asp polymorphisms in PCOS patients and non-diabetic healthy women.

22209983

Dasgupta S

2012

Role of luteinizing hormone ?-subunit gene variants among South Indian women with polycystic ovary syndrome.

22217188

Aziz M

2012

Polycystic ovary syndrome: infertility, cardiovascular, metabolic and obstetrical risks, laboratory and clinical outcomes -- the PICOLO Study.

22217993

Minella D

2011

SOS1 over-expression in genital skin fibroblasts from hirsute women: a putative role of the SOS1/RAS pathway in the pathogenesis of hirsutism.

22218441

Merino PM

2011

A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence.

22222107

Dowdy D

2012

Emotional needs of teens with polycystic ovary syndrome.

22222561

Williams S

2012

Surgical treatment of metabolic syndrome.

22223434

Rodrigues DM Jr

2012

Assessment of micronucleus frequency in the peripheral blood of female rats in persistent estrus treated with selective estrogen receptor modulators.

22223701

Koika V

2012

Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.